跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-CYCLOSPORINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-CYCLOSPORINE
Authorized
STANDARD
TEVA-CYCLOSPORINE
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
51b92919c47f6bcc
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
51b92919c47f6bcc
Drug Approval Canada Name
TEVA-CYCLOSPORINE
Product Name
TEVA-CYCLOSPORINE
Status
Marketed
Status Date
2017-12-04
Original Market Date
2017-12-04
Din
02462486
Drug Class
Human
Dosage Form
Emulsion
Route Of Administration
Ophthalmic
Schedule
Prescription
Ahfs
52:08.00
Atc Original
S01XA18 CICLOSPORIN
Atc Name
s 01 xa 18
Aig Number
0115996006
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
CYCLOSPORINE
0.05 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
51b92919c47f6bcc
Type
Standard
Back to Health Canada Approvals